Site Search
COVID-19 & influenza testing algorithm arms Mayo Clinic for the upcoming flu season - Insights
Flu season is just now unfolding. But this time, it’s piggy-backed with a pandemic, which threatens to spike with the colder weather as people huddle indoors. Adding to this conundrum is the unsettling fact that, for both COVID-19 and the...
Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights
This week's research roundup feature: Monoclonal immunoglobulin (MIg) crystalline nephropathies are rare lesions resulting from precipitation of MIgs in the kidney as crystalline inclusions. They can be categorized into lesions with...
Mayo Clinic Laboratory and Pathology Research Roundup: May 14 - Insights
This week's research roundup feature: Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPNs) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies,...
Mayo Clinic Laboratory and Pathology Research Roundup: May 7 - Insights
This week's research roundup feature: To standardize international normalized ratio (INR) measurements and improve data integrity by enabling electronic result transmission for warfarin monitoring, two point-of-care (POC) devices were...
Beyond the Test Result: Greg Widseth - Insights
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Autoimmune Neurology Testing - Mayo Clinic Laboratories
Recognized as a world leader in the diagnosis and treatment of autoimmune neurologic disorders, Mayo Clinic mounts unmatched resources for developing new diagnostic biomarkers and unique laboratory tests.
Justin Fugelsang and Zach Pedowitz have never met. Yet both young men were diagnosed with a rare form of Charcot-Marie-Tooth disease, called sorbitol dehydrogenase (SORD) deficiency, and both found clarity through Mayo Clinic Laboratories'...
Neurogenetic Testing - Mayo Clinic Laboratories
We offer comprehensive neurogenetic testing, backed by a multidisciplinary team of clinical neurology experts, laboratory scientists, and genetic counselors, to provide the highest standard for mutation detection and depth of coverage.
A decade-long search for answers ends at Mayo Clinic: Tyler Hart - Insights
After years of misdiagnosis, Tyler Hart found answers at Mayo Clinic, discovering he had NF155-IgG4 autoimmune nodopathy instead of CIDP
Demyelinating disease - Insights
Learn about our demyelinating disease testing, including multiple sclerosis, AQP4/MOG-associated disorders, and spinal cord disorders.
Thank you to all our staff during the time of COVID-19 - Insights
Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past...
CPT codes and LOINC update: November 2024 - Insights
This page lists updates posted to Mayo Clinic Labs during the month of November.
CPT codes and LOINC update: October 2024 - Insights
This page lists updates posted to Mayo Clinic Labs during the month of October.
September 2023 - Cytogenetics & Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cytogenetics & Hematopathology.
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.
Cayuga Medical Center: Building a world-class lab that drives revenue - Insights
Cayuga Medical Center sought to challenge the narrative that a hospital’s lab is an expensive liability by positioning themselves as the laboratory of choice in their area.
Custom gene ordering - Insights
With Mayo Clinic Laboratories’ custom gene ordering tool, clients can create specific gene panels to meet their patient’s individual needs.
Hematology, oncology, and hereditary test selection guide - Insights
The Hematology, Oncology, and Hereditary Test Selection Guide lets you search our next-generation sequencing test menu and choose the right panels for patients.
Learn how Mayo Clinic Laboratories’ outreach solutions can enhance and promote the clinical, business, and operational relevance of the hospital laboratory.
Mayo Clinic Laboratories works with hospitals and health care institutions to strengthen their ability to reach more patients and provide the best possible outcomes. These case studies feature some of challenges that Mayo Clinic...
Helicobacter pylori testing: 2021 update - Insights
In this month’s Hot Topic, Robin Patel, M.D., discusses Mayo Clinic Laboratories’ new PCR assay for detection of Helicobacter pylori detection and determination of clarithromycin resistance directly from stool.
Chromosomal microarray better informs brain tumor diagnosis - Insights
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Learn more about our pediatric oncology testing, which was carefully developed by a team of experts to provide efficient, actionable answers.
Neuromuscular disorders - Insights
Learn more about our specialized testing for neuromuscular diseases, including myasthenia gravis, Lambert-Eaton syndrome, and more.
Peripheral neuropathy - Insights
Learn about our peripheral neuropathy testing to identify autoimmune and genetic causes of the condition.
Our expert team of laboratory, medical, and business professionals is ready to help biopharma and biotech companies drive discovery, development, and execution.
Mayo Clinic BioPharma Diagnostics offers a full suite of solutions for clinical research organizations, pharmaceutical companies, and the in vitro diagnostics industry to accelerate research and development and to propel test creation. Each...
Answers From the Lab Archives - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Liquid biopsy cancer testing - Insights
Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
What started as a persistent headache for Spencer Lodin soon devolved into slowed speech, seizures, and hallucinations, symptoms which stumped ER doctors into thinking he had meningitis or was suffering from psychosis. Finally, specialized...
JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
Breast and Gynecological Cancer - Insights
Learn how our gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.
Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights
It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
Endocrinology Testing - Mayo Clinic Laboratories
Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing.
Vector-borne disease testing - Insights
Guided by an algorithmic approach that supports performing the right test on the right patient based on their geographic region, Mayo Clinic Laboratories offers a robust vector-borne disease test menu, which encompasses individual tests as...
Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
Check out how key tactics for laboratory outreach can increase revenues, decrease cost, and improve patient care.
Learn how to connect with Mayo Clinic Laboratories to begin an outreach engagement.
Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides possadasi/immitis, Histoplasma, Blastomyces, and...